GE buys interest in DNA

General Electric has scooped up Thermo Fischer Scientific's DNA purifying and cell-line growing technology for just over $1 billion, Bloomberg reports.

The deal helps both companies pursue their respective business objectives. Bloomberg notes that the deal means GE will now be able to promote technologies that aid discovery and manufacturing of medicines and diagnostics, somewhat counterbalancing its exit from consumer finance.

At the same time, Bloomberg notes, the divestiture could help Thermo Fischer get EU approval to acquire Life Technologies Corp. for $13.6 billion. This deal would put Life's genetic testing and mapping equipment under Thermo's roof.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.